| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409577 Single chain multivalent binding proteins with effector function |
| 04/02/2013 | US8409576 Use of IL-1beta compounds |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409572 Monoclonal antibodies with enhanced ADCC function |
| 04/02/2013 | US8409571 Methods of antagonizing signal transduction in spinal cord cells |
| 04/02/2013 | US8409570 Method of inducing apoptosis using anti-DR5 antibodies |
| 04/02/2013 | US8409568 Mutant antibody Fc domains and fusion proteins thereof |
| 04/02/2013 | US8409567 Toll-like receptor 3 antagonists |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | CA2553883C Anti-cancer antibodies with reduced complement fixation |
| 04/02/2013 | CA2532799C Human antibody molecules for il-13 |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2460392C Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 04/02/2013 | CA2402131C Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/28/2013 | WO2013044215A1 Vegf/dll4 binding agents and uses thereof |
| 03/28/2013 | WO2013043933A2 Cd27l antigen binding proteins |
| 03/28/2013 | WO2013043644A1 Methods using liver disease biomarkers |
| 03/28/2013 | WO2013043608A1 Removal of virucidal agents from biomolecule preparations |
| 03/28/2013 | WO2013043452A1 Anti-c-met antibodies |
| 03/28/2013 | WO2013043071A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | WO2013043070A2 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 03/28/2013 | WO2013042426A1 Antibody against affinity complex |
| 03/28/2013 | WO2013042053A2 Compounds for use in the treatment of alzheimer's disease |
| 03/28/2013 | WO2013041962A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 03/28/2013 | WO2013041901A1 Methods for preparing single domain antibody microarrays |
| 03/28/2013 | WO2013041846A2 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 03/28/2013 | WO2013041845A2 Animals, repertoires & methods |
| 03/28/2013 | WO2013041844A2 Antibodies, variable domains & chains tailored for human use |
| 03/28/2013 | WO2013041843A1 Cell differentiation |
| 03/28/2013 | WO2013041730A1 Serum half-life extension using immunoglobulin binding domains |
| 03/28/2013 | WO2013041722A1 Prolonged inhibition of interleukin-6 mediated signaling |
| 03/28/2013 | WO2013041707A1 Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
| 03/28/2013 | WO2013041687A1 Bispecific binding molecules for 5t4 and cd3 |
| 03/28/2013 | WO2013041617A1 METHOD FOR OBTAINING FAB FRAGMENTS FROM SINGLE ANTIBODY PRODUCING CELLS BY MULTIPLEXED PCR IN COMBINATION WITH TaqMan PROBES |
| 03/28/2013 | WO2013041462A1 Bispecific anti-egfr/anti igf-1r antibodies |
| 03/28/2013 | WO2013040766A1 Method and vaccine capable of inducing broad spectrum immune response against hiv |
| 03/28/2013 | WO2013019889A3 Bovine polyclonal antibody specific for human tnf |
| 03/28/2013 | WO2013006479A3 Mammalian cell culture |
| 03/28/2013 | WO2012178150A3 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies |
| 03/28/2013 | WO2012170807A3 Anti-pseudomonas psl binding molecules and uses thereof |
| 03/28/2013 | WO2012165925A3 Anti-c-met antibody having hgf activity and use thereof |
| 03/28/2013 | WO2012149334A3 Methods and compositions for the generation and use of conformation-specific antibodies |
| 03/28/2013 | WO2012076157A3 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 03/28/2013 | WO2012072268A8 Anti cd4 antibodies to prevent in particular graft -versus - host - disease (gvhd) |
| 03/28/2013 | WO2012037196A8 METHODS OF TREATING AUTOIMMUNE DISEASES WITH ANTI-FCεRI ANTIBODIES |
| 03/28/2013 | US20130079502 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 03/28/2013 | US20130079501 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 03/28/2013 | US20130079497 Pyrenyloxysulfonic acid fluorescent agents |
| 03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 03/28/2013 | US20130078717 Binding members-513 |
| 03/28/2013 | US20130078679 Polypeptides Having Cellobiohydrolase 1 Activity and Polynucleotides Encoding Same |
| 03/28/2013 | US20130078675 High affinity human antibodies to human il-4 receptor |
| 03/28/2013 | US20130078653 Antibodies, compositions, and assays for detection of cardiac disease |
| 03/28/2013 | US20130078269 Amyloid beta peptides, assemblies thereof, and related methods |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | US20130078262 Fc receptor binding proteins |
| 03/28/2013 | US20130078257 Use of an active substance binding to cd28 for producing a pharmaceutical composition for the treatment of b-cll |
| 03/28/2013 | US20130078253 Cancer targets and uses thereof |
| 03/28/2013 | US20130078251 Anti-mcsp antibodies |
| 03/28/2013 | US20130078250 Bispecific t cell activating antigen binding molecules |
| 03/28/2013 | US20130078249 Bispecific t cell activating antigen binding molecules |
| 03/28/2013 | US20130078248 Bispecific binding molecules binding to vegf and ang2 |
| 03/28/2013 | US20130078247 Bispecific binding molecules binding to dii4 and ang2 |
| 03/28/2013 | US20130078245 ANTIBODIES TO THE C3d FRAGMENT OF COMPLEMENT COMPONENT 3 |
| 03/28/2013 | US20130078244 Methods for detecting and regulating alopecia areata and gene cohorts thereof |
| 03/28/2013 | US20130078243 Conjugate molecule |
| 03/28/2013 | US20130078241 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 03/28/2013 | US20130078240 4-1bb binding molecules |
| 03/28/2013 | US20130078237 Cd27l antigen binding proteins |
| 03/28/2013 | US20130078236 Anti-CD28 humanized Antibodies |
| 03/28/2013 | US20130078234 Anti b7-h3 antibody |
| 03/28/2013 | US20130078216 Liver targeting molecules |
| 03/28/2013 | DE102011118015A1 IgY-Zusammensetzung für die Verwendung in der Zöliakie IgY composition for use in the celiac |
| 03/28/2013 | DE102011083595A1 Inhibition der Wirkung von Interleukin 1 beta zur Behandlung der Endometriose Inhibition of the effect of interleukin 1 beta for the treatment of endometriosis |
| 03/28/2013 | CA2849705A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | CA2849562A1 Vegf/dll4 binding agents and uses thereof |
| 03/28/2013 | CA2849409A1 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 03/28/2013 | CA2849318A1 Cd27l antigen binding proteins |
| 03/28/2013 | CA2849301A1 Multiplex mrm assay for evaluation of cancer |
| 03/28/2013 | CA2849274A1 Antibody against affinity complex |
| 03/28/2013 | CA2849195A1 Prolonged inhibition of interleukin-6 mediated signaling |
| 03/28/2013 | CA2849100A1 Srm/mrm assay for the fatty acid synthase protein |
| 03/28/2013 | CA2848346A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 03/28/2013 | CA2846436A1 Serum half-life extension using immunoglobulin binding domains |
| 03/28/2013 | CA2846432A1 Bispecific binding molecules for 5t4 and cd3 |
| 03/28/2013 | CA2846322A1 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 03/28/2013 | CA2846319A1 Antibodies, variable domains & chains tailored for human use |
| 03/28/2013 | CA2845147A1 Bispecific anti-egfr/anti igf-1r antibodies |
| 03/28/2013 | CA2844838A1 Method for obtaining fab fragments from single antibody producing cells by multiplexed pcr in combination with taqman probes |
| 03/28/2013 | CA2843771A1 Anti-c-met antibodies |
| 03/27/2013 | EP2573192A1 Method and kit for diagnosing aim-related illness |
| 03/27/2013 | EP2573175A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 03/27/2013 | EP2573121A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 03/27/2013 | EP2573120A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 03/27/2013 | EP2573119A1 Antibodies that bind IL-4 and/or IL-13 and their uses |
| 03/27/2013 | EP2573118A1 Antibodies that bind IL-4 and/or IL-13 and their uses |